CT19-01

Main Content

Allogeneic hematopoietic cell transplantation vs chimeric antigen receptor T-cell therapy for diffuse large B-cell lymphoma patients with prior autologous transplant failure or refractory disease.

Study #: CT19-01

Study Status: Published

Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: A noncomparative cohort analysis.

Citation

Hamadani M, Gopal AK, Pasquini M, Kim S, Qiu X, Ahmed S, Lazaryan A, Bhatt VR, Daly A, Lulla P, Ciurea S, Gauthier J, Agrawal V, Grover NS, Lekakis L, Modi D, Dahi PB, Herr MM, Johnson PC, Hashmi H, Hematti P, Locke FL.

Blood Advances. 2022, Jan 25: 6(2): 6(2):486-494. doi: 10.1182/bloodadvances.2021005788. Epub 2021, Oct 21. PMCID:PMC8791562.

PubMed

PMID: 34673903

Abstract